Request for Nominations of Candidates To Serve on the Advisory Committee on Breast Cancer in Young Women (ACBCYW), 82300 [2011-33576]
Download as PDF
<![CDATA[
82300
Federal Register / Vol. 76, No. 251 / Friday, December 30, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
srobinson on DSK4SPTVN1PROD with NOTICES
Request for Nominations of
Candidates To Serve on the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW)
The CDC is soliciting nominations for
membership on the ACBCYW. The
Committee provides advice and
guidance to the Secretary, HHS; the
Assistant Secretary for Health; and the
Director, CDC, regarding the formative
research, development, implementation
and evaluation of evidence-based
activities designed to prevent breast
cancer (particularly among those at
heightened risk) and promote the early
detection and support of young women
who develop the disease. The advice
provided by the Committee will assist in
ensuring scientific quality, timeliness,
utility, and dissemination of credible
appropriate messages and resource
materials.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. The Secretary, HHS, acting
through the Director, CDC, shall appoint
to the advisory committee nominees
with expertise in breast cancer, disease
prevention, early detection, diagnosis,
public health, social marketing, genetic
screening and counseling, treatment,
rehabilitation, palliative care, and
survivorship in young women, or in
related disciplines with a specific focus
on young women. Members may be
invited to serve for up to four years. The
next cycle of selection of candidates
will begin in the winter of 2012, for
selection of potential nominees to
replace members whose terms will end
on October 15, 2012 and October 15,
2013 respectively.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACBCYW
objectives https://www.cdc.gov/maso/
FACM/facmACBCYW.htm. The U.S.
Department of Health and Human
Services will give close attention to
equitable geographic distribution and to
minority and female representation so
long as the effectiveness of the
Committee is not impaired.
Appointments shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
HIV status, disability, and cultural,
religious, or socioeconomic status.
Nominees must be U.S. citizens, and
VerDate Mar<15>2010
19:02 Dec 29, 2011
Jkt 226001
cannot be full-time employees of the
U.S. Government.
Candidates should submit the
following items:
• Current curriculum vitae or resume,
including complete contact information
(name, affiliation, mailing address,
telephone numbers, fax number, email
address);
• A 150 word biography for the
nominee;
• At least one letter of
recommendation from a person(s) not
employed by the U.S. Department of
Health and Human Services. Candidates
may submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by HHS.
Nominations should be submitted
(postmarked or received) by January 25,
2012.
• Electronic submission: You may
submit nominations, including
attachments, electronically to
acbcyw@cdc.gov.
• Regular, Express or Overnight Mail:
Written nominations may be submitted
to the following addressee only:
Temeika L. Fairley, Ph.D., c/o ACBCYW
Designated Federal Officer, CDC, 4770
Buford Highway NE., Mailstop K–52,
Atlanta, Georgia 30341.
Telephone and facsimile submissions
cannot be accepted. Nominations may
be submitted by the candidate or by the
person/organization recommending the
candidate.
Candidates invited to serve will be
asked to submit the ‘‘Confidential
Financial Disclosure Form for Special
Government Employees Serving on
Federal Advisory Committees at the
Centers for Disease Control and
Prevention.’’ This form allows CDC to
determine whether there is a statutory
conflict between that person’s public
responsibilities as a Special Government
Employee and private interests and
activities, or the appearance of a lack of
impartiality, as defined by Federal
regulation. The form may be viewed and
downloaded at https://www.usoge.gov/
forms/oge450_pdf/oge450_
accessible.pdf. This form should not be
submitted as part of the nomination.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and the
Agency for Toxic Substances and
Disease Registry.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Dated: December 23, 2011.
Ronald Ergle,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2011–33576 Filed 12–29–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0827]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Revisions to
Labeling Requirements for Blood and
Blood Components, Including Source
Plasma
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
certain labeling requirements for blood
and blood components, including
Source Plasma. These requirements will
facilitate the use of a labeling system
using machine-readable information
that would be acceptable as a system for
labeling blood and blood components,
and the use of new labeling systems that
may be developed in the future.
Additionally, these requirements are
issued to help ensure the continued
safety of the blood supply and facilitate
consistency in labeling.
DATES: Submit either electronic or
written comments on the collection of
information by February 28, 2012.
ADDRESSES: Submit electronic
comments on the collection of
information to https://www.regulations.
gov. Submit written comments on the
collection of information to the Division
of Dockets Management (HFA–305),
Food and Drug Administration, 5630
Fishers Lane, rm. 1061, Rockville, MD
20852. All comments should be
identified with the docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Juanmanuel Vilela, Office of
SUMMARY:
E:\FR\FM\30DEN1.SGM
30DEN1
]]>Agencies
[Federal Register Volume 76, Number 251 (Friday, December 30, 2011)]
[Notices]
[Page 82300]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33576]
[[Page 82300]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Request for Nominations of Candidates To Serve on the Advisory
Committee on Breast Cancer in Young Women (ACBCYW)
The CDC is soliciting nominations for membership on the ACBCYW. The
Committee provides advice and guidance to the Secretary, HHS; the
Assistant Secretary for Health; and the Director, CDC, regarding the
formative research, development, implementation and evaluation of
evidence-based activities designed to prevent breast cancer
(particularly among those at heightened risk) and promote the early
detection and support of young women who develop the disease. The
advice provided by the Committee will assist in ensuring scientific
quality, timeliness, utility, and dissemination of credible appropriate
messages and resource materials.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
committee's objectives. The Secretary, HHS, acting through the
Director, CDC, shall appoint to the advisory committee nominees with
expertise in breast cancer, disease prevention, early detection,
diagnosis, public health, social marketing, genetic screening and
counseling, treatment, rehabilitation, palliative care, and
survivorship in young women, or in related disciplines with a specific
focus on young women. Members may be invited to serve for up to four
years. The next cycle of selection of candidates will begin in the
winter of 2012, for selection of potential nominees to replace members
whose terms will end on October 15, 2012 and October 15, 2013
respectively.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of ACBCYW objectives https://www.cdc.gov/maso/FACM/facmACBCYW.htm. The U.S. Department of Health and
Human Services will give close attention to equitable geographic
distribution and to minority and female representation so long as the
effectiveness of the Committee is not impaired. Appointments shall be
made without discrimination on the basis of age, race, ethnicity,
gender, sexual orientation, HIV status, disability, and cultural,
religious, or socioeconomic status. Nominees must be U.S. citizens, and
cannot be full-time employees of the U.S. Government.
Candidates should submit the following items:
Current curriculum vitae or resume, including complete
contact information (name, affiliation, mailing address, telephone
numbers, fax number, email address);
A 150 word biography for the nominee;
At least one letter of recommendation from a person(s) not
employed by the U.S. Department of Health and Human Services.
Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by HHS.
Nominations should be submitted (postmarked or received) by January
25, 2012.
Electronic submission: You may submit nominations,
including attachments, electronically to acbcyw@cdc.gov.
Regular, Express or Overnight Mail: Written nominations
may be submitted to the following addressee only: Temeika L. Fairley,
Ph.D., c/o ACBCYW Designated Federal Officer, CDC, 4770 Buford Highway
NE., Mailstop K-52, Atlanta, Georgia 30341.
Telephone and facsimile submissions cannot be accepted. Nominations may
be submitted by the candidate or by the person/organization
recommending the candidate.
Candidates invited to serve will be asked to submit the
``Confidential Financial Disclosure Form for Special Government
Employees Serving on Federal Advisory Committees at the Centers for
Disease Control and Prevention.'' This form allows CDC to determine
whether there is a statutory conflict between that person's public
responsibilities as a Special Government Employee and private interests
and activities, or the appearance of a lack of impartiality, as defined
by Federal regulation. The form may be viewed and downloaded at https://www.usoge.gov/forms/oge450_pdf/oge450_accessible.pdf. This form
should not be submitted as part of the nomination.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and the Agency for Toxic
Substances and Disease Registry.
Dated: December 23, 2011.
Ronald Ergle,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2011-33576 Filed 12-29-11; 8:45 am]
BILLING CODE 4163-18-P
